| 2.4 |
7.2 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.9 |
2.6 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 0.8 |
2.4 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.6 |
5.4 |
GO:0021830 |
interneuron migration from the subpallium to the cortex(GO:0021830) |
| 0.6 |
1.7 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.5 |
2.7 |
GO:0090273 |
regulation of somatostatin secretion(GO:0090273) |
| 0.5 |
2.5 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.5 |
1.4 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 0.5 |
2.3 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.4 |
2.1 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.4 |
1.3 |
GO:0014735 |
regulation of muscle atrophy(GO:0014735) |
| 0.4 |
2.4 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.4 |
1.1 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.4 |
1.1 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.4 |
1.4 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.4 |
1.4 |
GO:0035878 |
nail development(GO:0035878) |
| 0.4 |
1.1 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) glutamate secretion, neurotransmission(GO:0061535) |
| 0.3 |
1.7 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.3 |
0.9 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.3 |
1.2 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.3 |
2.1 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.3 |
0.6 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.3 |
0.8 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.3 |
1.6 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.3 |
1.5 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.2 |
0.7 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.2 |
1.9 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.2 |
0.4 |
GO:1904339 |
negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 0.2 |
0.4 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 0.2 |
0.6 |
GO:0050883 |
musculoskeletal movement, spinal reflex action(GO:0050883) |
| 0.2 |
0.8 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 0.2 |
0.6 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.2 |
0.6 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.2 |
0.8 |
GO:0043974 |
histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.2 |
0.6 |
GO:1904742 |
protein poly-ADP-ribosylation(GO:0070212) regulation of telomeric DNA binding(GO:1904742) |
| 0.2 |
0.6 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.2 |
0.9 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.2 |
0.9 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 |
0.4 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.2 |
0.5 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 |
0.5 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 |
0.7 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.2 |
1.6 |
GO:0033292 |
T-tubule organization(GO:0033292) |
| 0.2 |
3.9 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.2 |
1.8 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.2 |
1.6 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.2 |
0.3 |
GO:0006101 |
citrate metabolic process(GO:0006101) |
| 0.2 |
1.4 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.2 |
0.3 |
GO:1905154 |
negative regulation of membrane invagination(GO:1905154) |
| 0.2 |
0.8 |
GO:0034351 |
negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.2 |
1.4 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.2 |
0.2 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.2 |
0.5 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.1 |
0.6 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 |
1.2 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
0.3 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.1 |
0.3 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 0.1 |
2.0 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
0.5 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.1 |
1.3 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.1 |
0.7 |
GO:0010991 |
regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 |
2.7 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.1 |
0.4 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 0.1 |
2.1 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.1 |
0.5 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
0.6 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
0.9 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 |
0.3 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.1 |
0.3 |
GO:0019405 |
alditol catabolic process(GO:0019405) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 |
0.4 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.1 |
0.8 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 |
0.9 |
GO:0060013 |
righting reflex(GO:0060013) positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.1 |
0.4 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.1 |
0.5 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 |
0.6 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.1 |
0.8 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.1 |
0.3 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 |
0.6 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.1 |
0.7 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
| 0.1 |
0.3 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.1 |
0.7 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.1 |
0.6 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.1 |
0.7 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 |
1.3 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
0.4 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.1 |
0.2 |
GO:0008078 |
mesodermal cell migration(GO:0008078) |
| 0.1 |
1.0 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.1 |
0.1 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.1 |
0.4 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.1 |
0.9 |
GO:0045906 |
negative regulation of vasoconstriction(GO:0045906) |
| 0.1 |
0.8 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 |
0.4 |
GO:0035624 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.1 |
1.5 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
1.2 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
1.3 |
GO:1901841 |
regulation of high voltage-gated calcium channel activity(GO:1901841) |
| 0.1 |
0.4 |
GO:0002182 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.1 |
0.3 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.1 |
0.7 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
0.4 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.1 |
0.2 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.1 |
0.7 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 |
0.8 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.1 |
0.4 |
GO:0051798 |
positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 0.1 |
0.2 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.1 |
1.3 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.1 |
0.7 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 |
1.8 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 |
0.2 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.1 |
0.1 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 |
0.3 |
GO:0032055 |
negative regulation of translation in response to stress(GO:0032055) |
| 0.1 |
0.2 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.1 |
0.7 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 |
0.3 |
GO:0019042 |
viral latency(GO:0019042) |
| 0.1 |
0.2 |
GO:0032916 |
positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.1 |
0.1 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 0.1 |
0.2 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.1 |
0.3 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
0.3 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.1 |
0.6 |
GO:1904707 |
cellular response to reactive nitrogen species(GO:1902170) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.1 |
0.5 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.1 |
0.3 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.1 |
0.2 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.1 |
0.5 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.1 |
0.6 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 |
2.5 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 |
0.6 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 |
0.2 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 |
0.4 |
GO:0021775 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.1 |
0.5 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 |
0.4 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.1 |
0.4 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
0.3 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
| 0.1 |
0.2 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.1 |
0.4 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.1 |
0.7 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
0.4 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.1 |
0.8 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.1 |
0.4 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 |
0.2 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 |
0.4 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.1 |
0.2 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.1 |
0.3 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 |
0.5 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
0.1 |
GO:0072368 |
regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.1 |
0.2 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.1 |
1.5 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.1 |
0.5 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.4 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.1 |
1.7 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.1 |
0.6 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.1 |
0.5 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.7 |
GO:0043252 |
oligopeptide transport(GO:0006857) prostaglandin transport(GO:0015732) sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
0.5 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.1 |
0.2 |
GO:0048599 |
oocyte development(GO:0048599) |
| 0.1 |
0.4 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 |
1.2 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.1 |
0.2 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.1 |
0.1 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 |
0.8 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 |
0.4 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.0 |
0.8 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.0 |
0.1 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.0 |
0.1 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.0 |
0.8 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 |
0.8 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.0 |
0.2 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.0 |
0.2 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.0 |
0.3 |
GO:0098908 |
regulation of neuronal action potential(GO:0098908) |
| 0.0 |
0.2 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) serine phosphorylation of STAT protein(GO:0042501) |
| 0.0 |
0.4 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 |
0.4 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.0 |
0.4 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.0 |
0.3 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.0 |
0.1 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.0 |
0.4 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 |
0.7 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.6 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.0 |
0.2 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.0 |
0.1 |
GO:0090240 |
positive regulation of histone H4 acetylation(GO:0090240) |
| 0.0 |
1.0 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.0 |
0.6 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.0 |
1.1 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.0 |
0.3 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.0 |
0.3 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.0 |
0.5 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.0 |
0.6 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 |
0.4 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.0 |
0.7 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
0.4 |
GO:0090179 |
planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.0 |
0.2 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.0 |
0.2 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.0 |
0.6 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.1 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.0 |
1.1 |
GO:0006110 |
regulation of glycolytic process(GO:0006110) |
| 0.0 |
1.2 |
GO:0031061 |
negative regulation of histone methylation(GO:0031061) |
| 0.0 |
0.2 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.0 |
0.3 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
0.7 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.0 |
0.3 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 |
0.2 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.0 |
0.5 |
GO:0048741 |
skeletal muscle fiber development(GO:0048741) |
| 0.0 |
0.1 |
GO:0045627 |
positive regulation of T-helper 1 cell differentiation(GO:0045627) |
| 0.0 |
0.2 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.0 |
0.1 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.0 |
0.1 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.0 |
0.3 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.0 |
0.2 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.0 |
0.3 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.0 |
0.0 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.0 |
0.4 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
0.1 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.0 |
0.1 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.0 |
0.2 |
GO:0033005 |
positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.0 |
0.2 |
GO:1902715 |
positive regulation of interleukin-2 secretion(GO:1900042) positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.0 |
0.1 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.0 |
0.4 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.0 |
0.3 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
0.1 |
GO:0001919 |
regulation of receptor recycling(GO:0001919) |
| 0.0 |
0.4 |
GO:0031123 |
RNA 3'-end processing(GO:0031123) |
| 0.0 |
0.1 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.0 |
0.0 |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.0 |
0.1 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.0 |
0.1 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.0 |
0.3 |
GO:0035418 |
protein localization to synapse(GO:0035418) |
| 0.0 |
0.1 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.0 |
0.1 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.0 |
0.2 |
GO:0031440 |
regulation of mRNA 3'-end processing(GO:0031440) |
| 0.0 |
0.7 |
GO:0046676 |
negative regulation of insulin secretion(GO:0046676) |
| 0.0 |
0.4 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.0 |
0.5 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.0 |
0.1 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 |
0.4 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 |
0.1 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.0 |
0.2 |
GO:0035641 |
locomotory exploration behavior(GO:0035641) |
| 0.0 |
0.1 |
GO:0042119 |
neutrophil activation(GO:0042119) |
| 0.0 |
0.1 |
GO:0018377 |
N-terminal protein lipidation(GO:0006498) N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
| 0.0 |
1.3 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.2 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.0 |
0.7 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
0.7 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.0 |
0.7 |
GO:2001244 |
positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.0 |
0.4 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
0.3 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.0 |
0.0 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.0 |
0.1 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.0 |
1.2 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.0 |
2.0 |
GO:0071804 |
cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.0 |
0.5 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.0 |
0.2 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.0 |
0.2 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.0 |
0.2 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.0 |
0.1 |
GO:0051968 |
positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.0 |
0.2 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 |
0.1 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.0 |
0.2 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.0 |
0.1 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.0 |
0.0 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.0 |
0.0 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.0 |
0.3 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.2 |
GO:0030204 |
chondroitin sulfate metabolic process(GO:0030204) |
| 0.0 |
0.6 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 |
0.5 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.0 |
0.0 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.0 |
0.1 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.0 |
0.0 |
GO:0046686 |
response to cadmium ion(GO:0046686) |
| 0.0 |
1.0 |
GO:1903363 |
negative regulation of cellular protein catabolic process(GO:1903363) |
| 0.0 |
1.0 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.0 |
0.1 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
